ESTER DERIVATIVES OF THE PHENOLIC HYDROXYL GROUP OF BUPRENORPHINE ARE DESCRIBED THAT CAN BE USED IN THE TREATMENT OF OPIATE DEPENDENCY AND/OR MODERATE TO SEVERE PAIN. THE ESTERS HAVE AN ENHANCED BIOAVAILABILITY, AN ENHANCED DURATION OF ACTION, AND A REDUCED ABUSE POTENTIAL.